Acyclovir

Product NDC
50090-0638
11-digit product format
500900638
Labeler code
50090
Product ID
50090-0638_c810a647-fdb5-4772-97d4-c84e52d0c074
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Acyclovir
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA075382
Marketing category
ANDA
Marketing start
2009-10-22
Marketing end
0000-00-00
Substance
ACYCLOVIR
Active strength
800 mg/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-0638-0EA - Each50090-063831ed7665-89ad-475f-b0e0-1ed6b3a457c012018-09-05
50090-0638-2EA - Each50090-063838fa5261-f771-4e88-a5f5-a488dbcf2f6112018-09-05
50090-0638-3EA - Each50090-063856ec9c76-b770-45fa-b146-db938c8d7aa812022-12-07

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-0638-05009006380035 TABLET in 1 BOTTLE (50090-0638-0) 35 tablet2014-11-280000-00-00NoNoCurrent
50090-0638-25009006380270 TABLET in 1 BOTTLE (50090-0638-2) 70 tablet2014-11-280000-00-00NoNoCurrent
50090-0638-35009006380340 TABLET in 1 BOTTLE (50090-0638-3) 40 tablet2022-01-200000-00-00NoNoCurrent